Are you Dr. Evans?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 35 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
55 Lake Ave N
Worcester, MA 01655Phone+1 774-441-8230Fax+1 508-334-3428
Summary
- Dr. Thomas Evans, MD is an infectious disease specialist in Worcester, Massachusetts. He is currently licensed to practice medicine in Massachusetts, California, and New York. He is affiliated with UMass Memorial Medical Center.
Education & Training
University of California (San Francisco)Residency, Internal Medicine, 1983 - 1986
University of Virginia School of MedicineClass of 1983
Certifications & Licensure
CA State Medical License 2000 - 2026
MA State Medical License 2005 - 2026
NY State Medical License 1995 - 2024
UT State Medical License 1989 - 2012- American Board of Internal Medicine Internal Medicine
Clinical Trials
- A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP300 and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Adult Volunteers
- A Multicenter, Randomized, Placebo-Controlled, Double-Blinded, Phase I Trial to Evaluate the Safety and Immunogenicity of Live Recombinant Canarypox ALVAC-HIV vCP205 Combined With GM-CSF in Healthy, HIV-1 Uninfected Volunteers
Publications & Presentations
PubMed
- 14 citationsLong-term memory B-cell responses in recipients of candidate human immunodeficiency virus type 1 vaccines.Thomas G. Evans, Sharon E. Frey, Heidi Israel, Joseph Chiu, Raphaelle El-Habib
Vaccine. 2004-06-30 - 18 citationsThe use of Flt3 ligand as an adjuvant for hepatitis B vaccination of healthy adults.Thomas G. Evans, Muhammad S. Hasan, Laurent J. Galibert, Dania Caron
Vaccine. 2002-12-13
Grant Support
- Immune Responses To CMV DNA VaccinationNational Institute Of Allergy And Infectious Diseases2004
- Development Of A Cytomegalovirus DNA VaccineNational Institute Of Allergy And Infectious Diseases2004
- HSV Amplicon Vectors For HIV Vaccine DevelopmentNational Center For Research Resources2003
- Immunization Trials Designed To Induce Mucosal LmmunityNational Institute Of Allergy And Infectious Diseases2002
- Core--Clinical InvestigationNational Institute Of Allergy And Infectious Diseases2001–2002
- FLT 3 Ligand As Adjuvant For Hepatitis B VaccinationNational Center For Research Resources2000–2002
- Acyclovir W/ Glucocorticosteroids On UV Herpes LabialisNational Center For Research Resources2000–2002
- North-Central California-Center For AIDS ResearchNational Institute Of Allergy And Infectious Diseases2001
- HSV Amplicon Vectors For HIV Vaccine DevelopmentNational Institute Of Allergy And Infectious Diseases2001
- Use Of GM CSF As An Adjuvant For Hepatitis B VaccineNational Center For Research Resources1999–2000
- Novel Monoclonal Antibodies For Investigating GP120National Institute Of Allergy And Infectious Diseases1998–1999
